R.R. Brodie

724 total citations
42 papers, 570 citations indexed

About

R.R. Brodie is a scholar working on Analytical Chemistry, Pharmacology and Oncology. According to data from OpenAlex, R.R. Brodie has authored 42 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Analytical Chemistry, 9 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in R.R. Brodie's work include Analytical Methods in Pharmaceuticals (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Analytical Chemistry and Chromatography (6 papers). R.R. Brodie is often cited by papers focused on Analytical Methods in Pharmaceuticals (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Analytical Chemistry and Chromatography (6 papers). R.R. Brodie collaborates with scholars based in United States, Ireland and United Kingdom. R.R. Brodie's co-authors include L. F. Chasseaud, T. Taylor, Howard Hill, Kah Hoong Chang, Michael J. Kerin, Karl Sweeney, Gayle A. Baldock, A. Darragh, D. R. Hawkins and B Catanese and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Chromatography A and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R.R. Brodie

41 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.R. Brodie United States 15 135 110 84 77 76 42 570
Christina Graffner Sweden 17 151 1.1× 70 0.6× 77 0.9× 54 0.7× 80 1.1× 54 1.1k
Ebenezer B. Asafu-Adjaye United States 10 96 0.7× 84 0.8× 35 0.4× 47 0.6× 79 1.0× 14 476
Dilip Kumar Singh United States 13 92 0.7× 79 0.7× 58 0.7× 34 0.4× 69 0.9× 54 409
Amitava Dasgupta United States 21 118 0.9× 161 1.5× 132 1.6× 54 0.7× 179 2.4× 81 1.1k
Yu‐Luan Chen United States 14 131 1.0× 302 2.7× 63 0.8× 53 0.7× 72 0.9× 34 625
G.G. Skellern United Kingdom 20 201 1.5× 247 2.2× 131 1.6× 73 0.9× 82 1.1× 76 1.0k
Akira Yamaji Japan 13 51 0.4× 50 0.5× 71 0.8× 85 1.1× 85 1.1× 59 551
Gyanendra Nath Singh India 14 92 0.7× 62 0.6× 79 0.9× 19 0.2× 35 0.5× 46 484
Hironori Yoshitomi Japan 13 61 0.5× 42 0.4× 54 0.6× 28 0.4× 84 1.1× 37 424
John C. Reepmeyer United States 18 169 1.3× 190 1.7× 60 0.7× 27 0.4× 49 0.6× 34 945

Countries citing papers authored by R.R. Brodie

Since Specialization
Citations

This map shows the geographic impact of R.R. Brodie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.R. Brodie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.R. Brodie more than expected).

Fields of papers citing papers by R.R. Brodie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.R. Brodie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.R. Brodie. The network helps show where R.R. Brodie may publish in the future.

Co-authorship network of co-authors of R.R. Brodie

This figure shows the co-authorship network connecting the top 25 collaborators of R.R. Brodie. A scholar is included among the top collaborators of R.R. Brodie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.R. Brodie. R.R. Brodie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Erin B., Kerin B. Adelson, R.R. Brodie, et al.. (2021). Oncology Medical Home: ASCO and COA Standards. JCO Oncology Practice. 17(8). 475–492. 21 indexed citations
2.
Brodie, Frank, et al.. (2020). Management of a rhegmatogenous retinal detachment in a pregnant patient. American Journal of Ophthalmology Case Reports. 18. 100708–100708. 1 indexed citations
3.
Pai, Sara I., R.R. Brodie, Robert W. Carlson, et al.. (2020). Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit. Journal for ImmunoTherapy of Cancer. 8(1). e000112–e000112. 6 indexed citations
4.
Brodie, R.R., Stephen E. Langabeer, John Quinn, Máirín E. McMenamin, & Patrick Hayden. (2019). Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis. SHILAP Revista de lepidopterología. 7(12). 2579–2580. 2 indexed citations
5.
Chang, Kah Hoong, et al.. (2011). Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals. BMC Cancer. 11(1). 196–196. 82 indexed citations
6.
John, B. A., R.R. Brodie, Gayle A. Baldock, et al.. (2002). Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects. Xenobiotica. 32(8). 699–713. 11 indexed citations
7.
8.
Brodie, R.R. & Howard Hill. (2002). Validation issues arising from the new FDA guidance for industry on bioanalytical method validation. Chromatographia. 55(S1). S91–S94. 39 indexed citations
9.
Smith, G. T., et al.. (2002). The impact of stability and solubility of photodynamic therapies on method development. Chromatographia. 55(S1). S171–S175. 1 indexed citations
10.
Baldock, Gayle A., et al.. (1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics & Drug Disposition. 12(7). 481–492. 43 indexed citations
11.
Baldock, Gayle A., R.R. Brodie, L. F. Chasseaud, & T. Taylor. (1990). Determination of benzydamine and its N-oxide in biological fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 529(1). 113–123. 24 indexed citations
12.
Taylor, T., et al.. (1986). Plasma concentrations and relative bioavailability of naftidrofuryl from different salt forms. Biopharmaceutics & Drug Disposition. 7(4). 327–334. 10 indexed citations
13.
Brodie, R.R., L. F. Chasseaud, A. Darragh, et al.. (1986). Pharmacokinetics and bioavailability of the anti‐emetic agent bromopride. Biopharmaceutics & Drug Disposition. 7(3). 215–222. 7 indexed citations
14.
Brodie, R.R., et al.. (1985). Determination of naftidrofuryl in human plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 338(2). 433–437. 15 indexed citations
15.
Bechgaard, Helle, et al.. (1982). Bioavailability of indomethacin from two multiple-units controlled-release formulations. European Journal of Clinical Pharmacology. 21(6). 511–515. 26 indexed citations
16.
Brodie, R.R., et al.. (1982). Bioavailability of bemetizide and triamterene from a combination formulation. Biopharmaceutics & Drug Disposition. 3(4). 361–370. 7 indexed citations
17.
Brodie, R.R. & L. F. Chasseaud. (1982). Determination of 11-bromovincamine in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 228. 413–417.
18.
Chasseaud, L. F., T. Taylor, & R.R. Brodie. (1980). Prazepam metabolism in female subjects. Journal of Pharmacy and Pharmacology. 32(1). 652–653. 4 indexed citations
19.
Brodie, R.R., et al.. (1978). Biotransformation of methyl 5-cyclopropylcarbonyl-2-benzimidazolecarbamate (ciclobendazole) in rats and dogs.. Drug Metabolism and Disposition. 6(5). 518–527. 10 indexed citations
20.
Brodie, R.R., et al.. (1978). Determination of the thiazide diuretic bemetizide in the plasma and urine of humans by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 146(1). 152–156. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Graffner Breakdown of academic impact, for papers by Ebenezer B. Asafu-Adjaye Breakdown of academic impact, for papers by Dilip Kumar Singh Breakdown of academic impact, for papers by Amitava Dasgupta Breakdown of academic impact, for papers by Yu‐Luan Chen Breakdown of academic impact, for papers by G.G. Skellern Breakdown of academic impact, for papers by Akira Yamaji Breakdown of academic impact, for papers by Gyanendra Nath Singh Breakdown of academic impact, for papers by Hironori Yoshitomi Breakdown of academic impact, for papers by John C. Reepmeyer
Rankless by CCL
2026